City

Atlanta (2)

New York (1)

Stanford (1)

Condition

Stage II Gallbladder Cancer AJCC v8 (2)

Stage IIA Gallbladder Cancer AJCC v8 (2)

Stage IIB Gallbladder Cancer AJCC v8 (2)

Stage III Gallbladder Cancer AJCC v8 (2)

Stage IIIA Gallbladder Cancer AJCC v8 (2)

Stage IIIB Gallbladder Cancer AJCC v8 (2)

Stage I Gallbladder Cancer AJCC v8 (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

ECOG-ACRIN Cancer Research Group (1)

Emory University (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

cisplatin (2)

capecitabine (1)

gemcitabine (1)

gemcitabine hydrochloride (1)

lymphadenectomy (1)

partial hepatectomy (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

stage iib gallbladder cancer ajcc v8

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 Trial in Atlanta

Recruiting

Stage II Gallbladder Cancer AJCC v8
+5 more

Cisplatin
+3 more

Atlanta, Georgia

Emory University, Winship Cancer Institute

Jan 3, 2023

Stage I Gallbladder Cancer AJCC v8, Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8 Trial in Stanford,

Withdrawn

Stage I Gallbladder Cancer AJCC v8
+6 more

Capecitabine
+2 more

Stanford, California
+4 more

Jun 3, 2020